Search

everythinglearnresearchcommunity

for

Search:↓

High-frequency ultrasound can effectively visualize and assess hair loss.

A woman's complete hair loss condition improved after recovering from COVID-19.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Men with severe balding have a higher risk of getting very sick from COVID-19.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Androgens play a key role in causing alopecia by changing the hair growth cycle.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Lyophilized platelet-rich plasma is beneficial and effective for various medical treatments, including tissue regeneration and hair regrowth.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

New UVA-responsive nanocapsules effectively kill microorganisms in hair follicles when activated by light.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Exosomes from hair papilla cells and the Chinese medicine Liao Tuo Fang can potentially promote hair growth and could be used to develop hair growth drugs.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Lower LDL-c levels predict higher COVID-19 mortality.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.